This information is only intended for institutional investors domiciled in Switzerland. In particular, it is not intended for persons who are subject to a legal system prohibiting the access to or publication of this section of the website or the products listed therein or their distribution (due to the nationality of the person, their place of residence or for other reasons).
In addition, the website is exclusively aimed at qualified investors within the meaning of Article 10 (3), (3bis) and (3) of the Federal Act on Collective Investment Schemes (CISA) and Article 6 (2) of the Ordinance on Collective Investment Schemes (CISO).
All information provided in this website is provided for informational purposes only and does not constitute an investment recommendation, offer or solicitation to buy, hold or sell any financial or investment products. They do not constitute any investment, legal, tax and / or other advice.
Lomond Ofner assumes no responsibility or liability, including negligence and liability towards third parties, for any loss or direct or indirect damage or consequential loss of any kind suffered by the users of this website, directly or indirectly and incurred through the use, access or modification thereof.
This website is governed by the laws of Switzerland.
Fund 1
Entering clinical trials. Named as one of the top 3 investments in the US by an Investment KOL.
Non-invasive tumour diagnostic targeting cancer cells. Proprietary technology.
Non-invasive handheld heart monitor to determine heart health and cardiac risk factors.
Clinical trials completed.
European Innovation Award Winner
Series B just completed. Oversubscribed.
Development of multiple assets
AI based tool to manage all patient-physician interactions, assessments and processing
Soft launch in 3 markets.
Retail guide based on dietary preference and location
Concept, design, proprietary technology and strategic manufacturing partner in place.
Managing and documenting the supply chain from seed to mouth
Copyright © 2023 Lomond Ofner, Inh. Ofner - All Rights Reserved.